|Home | About | Journals | Submit | Contact Us | Français|
Reprogramming of somatic cell nuclei to yield induced pluripotent stem (iPS) cells makes possible derivation of patient-specific stem cells for regenerative medicine. However, iPS cell generation is asynchronous and slow (2–3 weeks), the frequency is low (, 0.1%), and DNA demethylation constitutes a bottleneck. To determine regulatory mechanisms involved in reprogramming, we generated interspecies heterokaryons (fused mouse embryonic stem (ES) cells and human fibroblasts) that induce reprogramming synchronously, frequently and fast. Here we show that reprogramming towards pluripotency in single heterokaryons is initiated without cell division or DNA replication, rapidly (1 day) and efficiently (70%). Short interfering RNA (siRNA)-mediated knockdown showed that activation-induced cytidine deaminase (AID, also known as AICDA) is required for promoter demethylation and induction of OCT4 (also known as POU5F1) and NANOG gene expression. AID protein bound silent methylated OCT4 and NANOG promoters in fibroblasts, but not active demethylated promoters in ES cells. These data provide the first evidence that mammalian AID is required for active DNA demethylation and initiation of nuclear reprogramming towards pluripotency in human somatic cells.
Reprogramming of somatic cell nuclei towards pluripotency has been achieved by nuclear transfer into enucleated oocytes1,2 and the introduction of four defined factors to generate iPS cells3-6. These remarkable advances enable the generation of patient-specific cells for tissue replacement, modelling human diseases in tissue culture, and drug discovery. However, an understanding of the molecular mechanisms underlying nuclear reprogramming has been elusive, largely due to the technical challenges associated with nuclear transfer and the low efficiency of iPS cell generation.
To identify new early regulators essential for nuclear reprogramming towards pluripotency, we capitalized on our previous experience with heterokaryons–cell fusion products that proved useful in determining the principles inherent to the maintenance of the differentiated state of somatic cells7-11. Specifically, these earlier studies, by us and others, showed that the ‘terminally differentiated’ state of human cells was not fixed, but could be altered, and the expression of previously silent genes typical of other differentiated states could be induced11-15. We showed that reprogramming in heterokaryons was influenced by DNA methylation status, tissue of origin, and the relative ratio of nuclei that dictates the balance of regulators11,15-17, consistent with recent experiments in iPS cells18-23. We reasoned that heterokaryons, generated by fusing mouse ES cells and human fibroblasts, could be used to elucidate mechanisms and identify new genes with a role at the onset of reprogramming towards pluripotency because reprogramming takes place in the presence of all ES cell factors, and the onset of reprogramming is synchronously initiated after fusion. The advantages of interspecies heterokaryons over previously used same-species cell fusion hybrids24,25 are that species differences allow a distinction of transcripts derived from the two fused cell types, and reprogramming is assessed immediately after fusion without the need for cell division or DNA replication. Heterokaryons constitute a third complementary approach to nuclear reprogramming that overcomes some of the limitations of nuclear transfer and iPS cell generation by facilitating mechanistic studies.
The use of heterokaryons in this report allowed us to study epigenetic and transcriptional changes critical to the initiation of reprogramming towards pluripotency. We focused on DNA demethylation–a known block to reprogramming that leads to partially reprogrammed iPS cells23, and also a key step for reprogramming by nuclear transfer26. Despite decades of effort, so far no consensus mammalian DNA demethylase has been identified27. Recently, AID has been implicated in DNA demethylation in zebrafish within hours after fertilization, acting in a complex that mediates deamination followed by DNA repair28. In mammals, AID is primarily known for its role in the generation of antibody diversity in Blymphocytes29, but has recently been detected in germ cells30. Our studies demonstrate a new role for AID in active DNA demethylation and reprogramming of mammalian somatic cells towards pluripotency.
To produce interspecies heterokaryons, mouse ES cells transduced with a green fluorescent protein (GFP) reporter gene were co-cultured with primary human fibroblasts transduced with a DsRed reporter gene, and fused using polyethylene glycol (PEG) (Fig. 1a and scheme in Supplementary Fig. 1). Fused GFP+ DsRed+ heterokaryons, which were readily sorted by fluorescence-activated cell sorting (FACS) (Fig. 1b) and identified using fluorescence microscopy, contained distinctly stained human and mouse nuclei when visualized with Hoechst dye (Fig. 1c, f). Because the efficiency of PEG fusion is low (0.6–1.0%), GFP+ DsRed+ heterokaryons were sorted twice and enriched to 80% purity (Fig. 1b). Using an antibody for Ki67, a nuclear protein present only in proliferating cells, we determined that cell division did not occur in 98±2% (mean±s.e.m.) of heterokaryons over the 3-day time period assayed after fusion (Fig. 1d, e). Furthermore, BrdU labelling was not detected in 94±4% of heterokaryons over the same time period, indicating the absence of DNA replication (Fig. 1f, g and Supplementary Figs 2 and 3). To favour reprogramming towards a pluripotent state, we skewed the ratio of the input cells so that ES cells outnumbered the fibroblasts as gene dosage and the proportion of proteins contributed by each cell type determines the direction of nuclear reprogramming in somatic cells16,31.
To determine whether ES-cell-specific genes were induced in the human fibroblast nuclei, the induction of human OCT4 and NANOG was assayed relative to ubiquitous GAPDH using species-specific primers (Supplementary Fig. 4). Messenger RNA isolated from sorted heterokaryons 1, 2 and 3 days after fusion was assessed by reverse transcription followed by semiquantitative PCR (RT–PCR) and real-time PCR (Fig. 2a,b). The day 0 controls tested initially were (1) human fibroblasts alone, (2) pre-PEG, unfused co-cultures of mouse ES cells and human fibroblasts, or (3) human fibroblasts treated with PEG to control for the effects of PEG and fusion. All of these day 0 controls gave similar results (data not shown) and the unfused co-culture control was used for all subsequent experiments. Notably, the induction of both human OCT4 and NANOG transcripts was evident as early as day 1 after fusion in heterokaryons but not in controls (Fig. 2a, b and Supplementary Fig. 5), indicating that the onset of expression of two key human pluripotency genes is rapid in heterokaryons. By day 1, expression of human OCT4 and NANOG (normalized to GAPDH in the same samples), had increased 5-fold relative to the control (day 0) and persisted at 10-fold higher levels on days 2 and 3 (Fig. 2b). Human-specific primers were used to determine whether other key pluripotency genes in addition to OCT4 and NANOG were induced using real-time PCR, including KLF4, ESRRB, TDGF1 (also known as CRIPTO), SOX2 and c-Myc (also known as MYC) (Supplementary Fig. 6). ESRRB32 and TDGF1 (ref. 33), which have been shown to be essential for maintaining ES cell self-renewal32 and are targets of OCT4 and NANOG34, were found to be upregulated 3-fold and 2.5-fold, respectively, in heterokaryons on day 2 after fusion (Supplementary Fig. 6). SOX2 is already expressed in human fibroblasts and its promoter is extensively demethylated pre-fusion, in agreement with findings in mouse fibroblasts23; its expression did not increase after fusion. Expression of KLF4 (ref. 35), which is functionally interchangeable with ESRRB, did not change in heterokaryons at day 2 after fusion (Supplementary Fig. 6).
To assess the efficiency of nuclear reprogramming in human fibroblasts after fusion, single FACS-sorted heterokaryons were analysed by nested RT–PCR for the three human transcripts OCT4, NANOG and GAPDH(control), using two sets of human-specific primers in each case (Fig. 2c). As expected, no human gene products were detected in mouse ES cells (control), and only human GAPDH was detected in human fibroblasts (control) (Supplementary Fig. 4). Notably, 70% of single FACS-sorted heterokaryons from three independent fusion experiments isolated on day 3 after fusion expressed both human OCT4 and NANOG (Fig. 2c, d and Supplementary Fig. 7), showing that a high proportion of heterokaryons initiated reprogramming towards pluripotency. This is in marked contrast to the slow and inefficient induction of OCT4 and NANOG expression in iPS cells (, 0.1% of the total population) in 2–3 weeks3-5,36.
Because DNA demethylation has been shown to be a major limiting step in reprogramming fibroblasts towards iPS cells23, we analysed the time course and extent of demethylation of the human OCT4 and NANOG promoters in heterokaryons. DNA was isolated from heterokaryons on days 1, 2 and 3 after fusion and subjected to bisulphite conversion. Human OCT4 and NANOG promoter regions were amplified by PCR using human- and bisulphite-specific primers (Supplementary Fig. 4) and the products were cloned and sequenced. DNA demethylation was evident at the human OCT4 and NANOG promoters and progressively increased through day 3 (Fig. 3a). In contrast, the β-globin (HBB) HS2 locus remained methylated throughout, indicating that the DNA demethylation was specific (data not shown). The time course and progressive accumulation of demethylated CpG sites in the human OCT4 and NANOG promoters (Fig. 3b) parallel the progressive increase in transcript accumulation observed over the same 3-day time period using real-time PCR (Fig. 2b). Notably, promoter demethylation and activation of pluripotency genes in human somatic cells take place in the absence of Ki67 or BrdU labelling (Fig. 1e, g); thus, demethylation is active and independent of cell division and DNA replication.
We focused on AID as a candidate factor with a role in mammalian DNA demethylation as it has been detected in mammalian pluripotent germ cells30 and implicated in DNA demethylation in zebrafish post fertilization28. We assayed mouse ES cells and human fibroblasts for AID expression using real-time PCR. Although AID expression in somatic cells is generally thought to be restricted to B lymphocytes, we detected AID mRNA in human fibroblasts as well as mouse ES cells, albeit at greatly reduced levels (5% and 15%, respectively) compared to Ramos, a B-lymphocyte cell line (Supplementary Fig. 8). To investigate the role of AID in these cells, we performed a transient knockdown of mouse and human AID mRNAs by transfection of three distinct, non-overlapping siRNAs to different sequences within the AID coding region, and a fourth siRNA specific to the non-coding 3′ untranslated region (UTR) of AID, to rule out off-target effects and ensure that the results were specific to AID (Supplementary Fig. 9). A fifth siRNA with 50% identity to the AID coding region was used as a control. The extent and timing of knockdown was first confirmed in control mouse ES cells in which siRNA-1, -2, -3 and -4 reduced AID transcripts at day3 post-transfection as compared to the control siRNA (Supplementary Fig. 10, top). AID protein was detected in ES cell lysates. Knockdown of AID protein by 88% correlated well with the mRNA reduction by 81% (Supplementary Fig. 11). In human fibroblasts, AID transcripts were reduced by all of the siRNAs (Supplementary Fig. 10, bottom). These data show that AID is present and can be efficiently reduced by four distinct siRNAs in both ES cells and fibroblasts.
To assess the initiation of reprogramming in heterokaryons subjected to AID knockdown, the expression of human OCT4 and NANOG relative to GAPDH was assessed by real-time PCR. For heterokaryon experiments, siRNAs were transfected into both the mouse ES cells and the human fibroblasts 24 h before fusion (see Supplementary Fig. 1 for scheme). A persistent knockdown of AID was detected by real-time PCR in heterokaryons using each of the four siRNAs on days 2 and 3 after fusion relative to heterokaryons transfected with the control siRNA (Fig. 4a). Notably, both OCT4 and NANOG gene induction was greatly inhibited using siRNA-1 and siRNA-2 on day 2 after fusion, and siRNA-3 and siRNA-4 on day 3 after fusion, as compared to using the control siRNA (Fig. 4a). All siRNAs resulted in a similar block of OCT4 and NANOG activation. These observations indicate that the effect of AID is extremely dosage-sensitive, as a 35% knockdown led to a similar inhibition of pluripotency gene induction as a 96% knockdown. Together, these data show that all four siRNAs to AID used here efficiently inhibited OCT4 and NANOG activation by at least 80%.
To assess the effect of AID knockdown on promoter demethylation, we assayed the CpG methylation status of the human OCT4 and NANOG promoters in heterokaryons. Both day 2 and 3 heterokaryons subjected to AID knockdown using each of the four siRNAs showed a profound inhibition of CpG demethylation in the human OCT4 and NANOG promoters as compared to the control (Fig. 4b, c). A summary of the bisulphite sequencing data for all the siRNA knockdown experiments is shown in Supplementary Fig. 12. In parallel with the reduction in demethylation of the OCT4 and NANOG promoters after AID knockdown, the induction of OCT4 and NANOG transcripts was reduced by at least 80% on days 2 and 3, relative to the control (Fig. 4a). These data show that promoter demethylation is critical to the expression of these two pluripotency genes and that AID is required for mammalian DNA demethylation in somatic cell reprogramming.
To investigate further the requirement and specificity of AID for initiating reprogramming, we tested its ability to accelerate reprogramming, and to rescue the DNA demethylation block caused by the siRNA knockdown in heterokaryons. Therefore, human AID (hAID) was transiently overexpressed in mouse ES cells before siRNA transfection (see scheme in Supplementary Fig. 1). In two separate experiments, when AID was overexpressed twofold or fourfold relative to the control in heterokaryons at day 1 after fusion, there was no acceleration in promoter demethylation or reprogramming (Supplementary Fig. 13). However, after overexpression of hAID in heterokaryons undergoing transient knockdown by siRNA-3, there was a complete rescue of NANOG promoter demethylation and gene expression and a partial rescue of OCT4 promoter demethylation and gene expression (Supplementary Fig. 14). The lack of reprogramming acceleration and partial rescue observed for OCT4 could possibly be due to the kinetics of human OCT4 and NANOG promoter demethylation, which in heterokaryons may require at least 1 day to occur, or by the lack of other factors that work together with AID. These data show that the added hAID is functional and rule out any non-specific effects of the siRNA, further confirming the specific and essential role of AID in DNA demethylation at the onset of reprogramming towards pluripotency.
To validate the role of AID in DNA demethylation of human OCT4 and NANOG promoters further, we tested whether AID specifically binds to these promoter regions by performing chromatin immunoprecipitation (ChIP) experiments using an anti-AID antibody, previously validated for ChIP37. The promoter regions assessed in ChIP experiments were designed to be within the OCT4 and NANOG promoter regions that were analysed for CpG demethylation by bisulphite sequencing (Fig. 5 and Supplementary Fig. 15). In human fibroblasts, the ChIP analyses showed significant binding of AID to both human OCT4 (sixfold) and human NANOG (eightfold) promoters (Fig. 5). Thus, AID binds to the heavily methylated promoter regions of human OCT4 and NANOG in fibroblasts that undergo demethylation during reprogramming. As controls, AID binding to the promoter of the IgM constant region (Cμ) was significant, as expected38, whereas no binding was observed for THY1.1 (also known as CD90.1), which is expressed in fibroblasts.
In contrast to fibroblasts, no AID binding was observed at the promoter regions of Oct4 and Nanog in mouse ES cells despite the higher levels of AID protein in ES cells, presumably because these promoters are active and demethylated (Fig. 5). As controls, AID binding was detected at the promoter of Cdx2, a gene not expressed in undifferentiated ES cells39, but was absent from the p53 (also known as Trp53) promoter, as previously reported37. Together, these findings provide strong support for a direct involvement of AID in DNA demethylation and the sustained expression of human NANOG and OCT4 leading to the onset of reprogramming towards pluripotency.
DNA demethylation is essential to overcome gene silencing and induce temporally and spatially controlled expression of mammalian genes, yet no consensus mammalian DNA demethylase has been identified despite years of effort27. Evidence of DNA demethylation by 5-methyl-cytosine DNA glycosylases has been shown in plants40,41, but mammalian homologues such as thymine DNA glycosylase (TDG) or the methyl-CpG-binding domain protein 4 (MBD4) have not exhibited comparable functions42,43. As an alternative to direct demethylation, it has been postulated that the deamination of cytosine followed by DNA repair could lead to DNA demethylation44. AID belongs to a family of cytosine deaminases (AID, APOBEC1, 2 and 3 subgroups) that have established roles in generating antibody diversity in B cells, RNA editing and antiviral response45. Both AID and APOBEC1 are expressed in progenitor germ cells, oocytes and early embryos and have a robust 5-methyl-cytosine deaminase activity in vitro30, resulting in a T-G mismatch that is repaired through the base excision DNA repair (BER) pathway, and could theoretically lead to DNA demethylation without replication. Recently in zebrafish embryos, AID was implicated as a member of a tripartite protein complex along with MBD4 and GADD45A, causing cytosine deamination and leading to base excision by MBD4 (ref. 28). The third component GADD45A lacks enzymatic activity and its role in repair-mediated DNA demethylation and gene activation in Xenopus oocytes remains a matter of debate46,47.
Our data provide new evidence implicating AID in active DNA demethylation in mammalian cells, and demonstrate that AID-dependent DNA demethylation is an early epigenetic change necessary for the induction of pluripotency genes in human fibroblasts. Knockdown of AID in heterokaryons prevented DNA demethylation of the human OCT4 and NANOG promoters and the expression of these pluripotency factors by fibroblast nuclei. Indeed, initiation of nuclear reprogramming towards pluripotency was inhibited in human somatic fibroblasts when AID-dependent DNA demethylation was reduced, providing strong evidence that AID is a crucial regulator for the onset of reprogramming. The inhibitory effects of AID reduction were rescued by hAID overexpression with a complete rescue observed for NANOG and a partial rescue observed for OCT4. Moreover, AID binding was observed at silent methylated OCT4 and NANOG promoters in fibroblasts but not in active unmethylated OCT4 and NANOG promoters in ES cells, demonstrating its specific role in DNA demethylation. Previous studies that used cell fusion to analyse reprogramming to pluripotency could not distinguish the products of the two nuclei because the cells were derived from the same species24,25. A recent study used heterokaryons to reprogram lymphocytes towards pluripotency, however, only modest demethylation changes at the OCT4 promoter were observed that did not increase with time48, possibly owing to differences in the cell types and methods used for isolating heterokaryons. The high efficiency of reprogramming in heterokaryons achieved here allowed the discovery of a regulator critical to the induction of five pluripotency genes including OCT4 and NANOG, the first known markers of stable reprogramming leading to the generation of iPS cells. The heterokaryon platform can now be exploited (1) to determine the other components of the mammalian DNA demethylation complex (glycosylase and other DNA repair enzymes) that are likely to work together with AID to mediate active DNA demethylation (Fig. 6), and (2) to perform an unbiased search for other regulators of nuclear reprogramming by screening for human genes that are expressed immediately after cell fusion. Future studies will determine whether expression of AID alone or in conjunction with these other molecules will enhance the generation of iPS cells.
GFP+ mouse ES cells and DsRed+ human fetal lung primary fibroblasts were generated by transduction with retroviral constructs and fused to form non-dividing, multinucleated heterokaryons as previously described31. GFP+ DsRed+ heterokaryons were sorted twice by flow-cytometry (FACSVantage SE, BD Biosciences) and analysed for gene expression and methylation.
For antibody staining, GFP+ DsRed+ heterokaryons were cytospun and stained. Images were acquired using an epifluorescent microscope (Axioplan2, Carl Zeiss MicroImaging), Fluar ×20/0.75 or ×40/0.90 objective lens, and a digital camera (ORCA-ER C4742-95, Hamamatsu Photonics). The software used for acquisition was OpenLab 4.0.2 (Improvision).
BrdU was added to mouse ES cell and human fibroblast co-cultures 3 h after PEG-induced fusion. Labelling and antibody staining was performed using the BrdU Labelling and Detection Kit I (Roche).
Single cells were directly sorted by FACS. Collection of cells and the subsequent two-step multiplex nested RT–PCR were performed directly from cell lysates using all three human and gene-specific primers (OCT4, NANOG and GAPDH) as described in Methods.
Bisulphite treatment was performed on DNA isolated from FACS sorted heterokaryons (2,000–10,000 cells) using the Epitect Bisulfite Kit (Qiagen). Nested PCR for regions of the human OCT4 (ref. 18) and NANOG promoters was performed using human- and bisulphite-specific primers. PCR products from second-round bisulphite-specific PCR amplification were cloned and sequenced as described previously17.
For siRNA transfection, ES cells and primary fibroblasts were plated at 50–60% confluence the day before transfection. siRNAs (Dharmacon) were transfected using siImporter (Millipore).
ChIP was performed as previously described49. ChIP data was presented as normalized to input DNA and as the mean± s.e.m.
Data are presented as the mean±s.e.m. Comparisons between groups used the Student's t-test assuming two-tailed distributions.
GFP+ mouse ES cells and DsRed+ human fetal lung primary fibroblasts were generated by transduction with retroviral constructs as previously described31, and fused to form non-dividing, multinucleated heterokaryons. Cells were first co-cultured for 12 h in ES cell media and then treated with PEG 1500 (Roche) for 2 min at 37 °C, followed by four successive washes with DMEM. ES cell media was replaced after washing and every 12 h thereafter. GFP+ DsRed+ heterokaryons were sorted twice by flow-cytometry (FACSVantage SE, BD Biosciences) and analysed for gene expression and methylation.
Heterokaryons were sorted twice in PBS with 2.5% (v/v) goat serum and 1 mM EDTA, and cytospun for 5 min. The cytospun GFP+DsRed+ heterokaryons were stained with Hoechst 33342, and imaged. For antibody staining, cytospun cells were fixed, permeabilized and blocked using 20% FBS in PBS. Cells were incubated with the mouse anti-Ki67 antibody (Dako Denmark A/S) at 1:100 dilution in blocking buffer for 1 h, rinsed three times in PBS, and then incubated with a goat anti-mouse Cascade blue secondary antibody (Millipore) at 1:500 dilution for 30 min, rinsed three times, mounted with Fluoromount-G and imaged. Images were acquired using an epifluorescent microscope (Axioplan2, Carl Zeiss MicroImaging), Fluar ×20/0.75 or ×40/0.90 objective lens, and a digital camera (ORCA-ER C4742-95, Hamamatsu Photonics). The software used for acquisition was OpenLab 4.0.2 (Improvision).
BrdU was added to mouse ES cell and human fibroblast co-cultures 3 h after PEG-induced fusion. Labelling and antibody staining was performed using the BrdU Labelling and Detection Kit I (Roche).
RNA was prepared from ES cells, fibroblasts and twice-sorted heterokaryons at different times post fusion or after siRNA treatment using the RNeasy micro kit (Qiagen). Total RNA for each sample was reverse transcribed using the Superscript First-Strand Synthesis System for RT–PCR (Invitrogen). The reverse-transcribed material was subjected to PCR using Go GreenTaq DNA polymerase (Promega). Human-specific primers were designed for analysing the expression of OCT4, NANOG and GAPDH. Primers used for AID and GAPDH in the siRNA treatment experiments amplify both human and mouse transcripts to assess the total levels of AID and GAPDH in heterokaryons. Human-specific primers used for RT–PCR and quantitative PCR are: OCT4 F 5′-TCGAGAACCGAGTGAGAGGC-3′, R 5′-CACACTCGGACCACATCCTTC-3′; NANOG F 5′-CCAACATCCTGAACCTCAGCTAC-3′, R 5′-GCCTTC TGCGTCACACATT-3′; GAPDH F 5′-TGTCCCCACTGCCAACGTGTCA-3′, R 5′-AGCGTCAAAGGTGGAGGAGTGGGT-3′. Non-species-specific primer sequences for assessing knockdown after siRNA treatment are as follows: GAPDH F 5′-ACCACAGTCCATGCCATCAC-3′, R 5′-TCCACCACCCTGTTGCTGTA-3′; AID F 5′-AAAATGTCCGCTGGGCTAAG-3′, R 5′-AGGTCCCAGTCCGAGATGTAG-3′.
Real-time PCR was performed using an ABI 7900HT Real time PCR system using the Sybr Green PCR mix (Applied Biosystems). Samples were cycled at 94 °C for 2 min, 40 cycles of: 94 °C for 20s, 58 °C for 45 s.
FACS-sorted heterokaryons (2,000–10,000 cells) were collected in 20 μl PBS. DNA was extracted using the DNeasy Tissue Kit (Qiagen). Bisulphite treatment was performed using the Epitect Bisulfite Kit (Qiagen). Nested PCR for regions of the human OCT4 and NANOG promoters was performed using human- and bisulphite-specific primers. Samples were cycled for the first and second nested PCR at 94 °C for 2 min, 30 cycles of 94 °C for 20 s, 61 °C for 30 s, 68 °C for 30 s. PCR products from second-round bisulphite-specific PCR amplification were cloned and sequenced as described before17.
Single-cell collection. Single heterokaryons were directly sorted by FACS (FACSVantage SE, BD Biosciences) into PCR tubes containing 9-μl aliquots of RT–PCR lysis buffer. The buffer components included commercial RT–PCR buffer (SuperScript One-Step RT–PCR Kit Reaction Buffer, Invitrogen), RNase inhibitor (Protector RNase Inhibitor, Roche) and 0.15% IGEPAL detergent (Sigma). After a short pulse-spin, the PCR-tubes were immediately shock-frozen and stored at −80 °C for subsequent analysis.
Two-step multiplex nested single-cell RT–PCR. Cell lysates were first reverse-transcribed using the human-specific primer pairs for OCT4, NANOG and GAPDH (Supplementary Table 2, external primers; Supplementary Fig. 1b) using SuperScript One-Step RT–PCR Kit (Invitrogen). In brief, the RT–PCR was performed in the same PCR cell-lysis tubes by addition of an RT–PCR-reaction mix containing the gene-specific primer pairs and RNase inhibitor. Genomic products were excluded by designing and using intron-spanning primer sets for the first and second round PCR and nested RT–PCR to ensure greater specificity. In the first step, the reverse transcription reactions were carried out at 55 °C for 30 min, followed by a 2-min step at 94 °C. Subsequently, 30 cycles of PCR amplification were performed as follows: 94 °C for 30 s; 58 °C for 30 s; 68 °C for 30s. In the final PCR step, the reactions were incubated for 3 min at 68 °C. The completed reactions were stored at 4 °C.
In the second step of the PCR protocol, the completed RT–PCR reaction from the first step was diluted 1:1 with water. One per cent of these reactions were replica transferred into new reaction tubes for the second round of PCR, which was performed for each of the genes separately using nested gene-specific internal primers, for greater specificity, in a total reaction volume of 20 μl (Platinum Taq Super-Mix HF, Invitrogen). Thirty cycles of PCR amplification were performed as follows: 94 °C for 30 s; 58 °C for 30 s; 68 °C for 30 s. In the final PCR step, the reactions were incubated for 3 min at 68 °C. The completed reactions were stored at 4 °C. The second-round PCR products were then subjected to gel electrophoresis using one-fifth of the reaction volumes and 1.4% agarose gels.
GFP− (non-GFP) mES and DsRed+ hFb co-cultures treated with PEG were trypsinized and resuspended in 3 ml FACS buffer. Cells were incubated for 30 min at room temperature with biotin mouse anti-human CD90.1 (BD Pharmingen) at a dilution of 1:5,000. The cells were washed once, resuspended in 3 ml FACS buffer, and incubated for 30 min at room temperature with 10 μl of Dynabeads Biotin Binder (Invitrogen). Beads were collected by magnetic isolation, washed twice and the enriched heterokaryons were cytospun.
To visualize AID protein knockdown in mouse ES cells, cell lysates were collected 3 days after transfection with control siRNA or siRNA-3. Detection of AID in these samples was performed from 170 μg of whole cell lysate using anti mouse-AID (L7E7, Cell Signaling, dilution 1:500). The membrane was stripped and probed with anti-mouse α-tubulin (Sigma, dilution 1:20,000) for the loading control.
We thank O. Alkan for generating retroviral constructs for GFP and DsRed expression; R. Doyonnas for helping to standardize FACS isolation of heterokaryons; Y. Liao for performing the initial experiments showing demethylation in heterokaryons; M. PajÇini for technical assistance with the BrdU experiments; D. Schatz and S. Unniraman for providing the human AID construct; F. Alt for his generous provision of antibody to AID; J. A. Dahl for discussions about chromatin immunoprecipitation assays; H. Chang for use of the Bioruptor sonicator; and M. Wernig, G. Sen, C.-Z. Chen and J. Pomerantz for comments on the manuscript. This work was supported by a National Science Foundation Graduate Research Fellowship awarded to J.J.B., National Institutes of Health (NIH) training grant AI007328 to M.D., and NIH grants AG009521, AG024987 and support from the Baxter Foundation to H.M.B.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
Supplementary Information is linked to the online version of the paper at www.nature.com/nature.
Reprints and permissions information is available at www.nature.com/reprints.
The authors declare no competing financial interests.